PDF(Pubmed)
Abstract：
BACKGROUND: Persistent symptoms after SARS CoV-2 infection such as fatigue, shortness of breath, and cognitive dysfunction that cannot be explained by an alternative diagnosis have been termed long COVID and present a significant emerging public health problem. Current approaches include rehabilitation and symptom management involving multiple health disciplines and as yet there are no pharmaceutical approaches other than routine symptom management. Manual lymph drainage (MLD) has been used to support recovery during pulmonary rehabilitation and reduce chronic inflammation including symptoms associated with long COVID.
METHODS: Two adult females who had reported long-COVID symptoms more than 10 weeks after the resolution of the acute infection were treated with MLD by Remedial Therapists trained in the Dr Vodder method of MLD. Respiratory function (Peak Flow Meter) and blood oxygen levels (Oximeter) were recorded before and after a one-minute sit-to-stand test prior to the treatment. The Dyspnea-12 Questionnaire, the Revised Piper Fatigue Scale, and Likert scales were used to collect client-reported outcomes. Six 45-min treatments were applied weekly, with a follow-up review and treatment at three months. In both cases, all outcomes improved after the third treatment with further improvement noted at three months.
CONCLUSIONS: MLD may offer a non-invasive, non-pharmaceutical approach to the resolution of long-COVID symptoms such as cough, breathlessness, and fatigue.
METHODS: Two adult females who had reported long-COVID symptoms more than 10 weeks after the resolution of the acute infection were treated with MLD by Remedial Therapists trained in the Dr Vodder method of MLD. Respiratory function (Peak Flow Meter) and blood oxygen levels (Oximeter) were recorded before and after a one-minute sit-to-stand test prior to the treatment. The Dyspnea-12 Questionnaire, the Revised Piper Fatigue Scale, and Likert scales were used to collect client-reported outcomes. Six 45-min treatments were applied weekly, with a follow-up review and treatment at three months. In both cases, all outcomes improved after the third treatment with further improvement noted at three months.
CONCLUSIONS: MLD may offer a non-invasive, non-pharmaceutical approach to the resolution of long-COVID symptoms such as cough, breathlessness, and fatigue.
摘要：
背景：SARSCoV-2感染后的持续症状，如疲劳，呼吸急促,和不能用替代诊断解释的认知功能障碍被称为长COVID，并提出了一个正在出现的重大公共卫生问题。目前的方法包括涉及多种健康学科的康复和症状管理，除了常规症状管理外，还没有其他药物方法。手动淋巴引流（MLD）已用于支持肺部康复期间的恢复，并减少慢性炎症，包括与长期COVID相关的症状。
方法：两名在急性感染消退后10周以上报告长期COVID症状的成年女性，由接受过MLDDrVoder方法培训的补救治疗师接受MLD治疗。在治疗前进行一分钟的静坐试验之前和之后,记录呼吸功能(峰值流量计)和血氧水平(血氧计)。呼吸困难-12问卷，修订后的管道疲劳量表,和Likert量表用于收集客户报告的结果。每周进行6次45分钟的治疗，在三个月时进行随访和治疗。在这两种情况下，第三次治疗后,所有结局均有所改善,3个月时进一步改善.
结论：MLD可能提供非侵入性，解决咳嗽等长期COVID症状的非药物方法，呼吸困难,和疲劳。
方法：两名在急性感染消退后10周以上报告长期COVID症状的成年女性，由接受过MLDDrVoder方法培训的补救治疗师接受MLD治疗。在治疗前进行一分钟的静坐试验之前和之后,记录呼吸功能(峰值流量计)和血氧水平(血氧计)。呼吸困难-12问卷，修订后的管道疲劳量表,和Likert量表用于收集客户报告的结果。每周进行6次45分钟的治疗，在三个月时进行随访和治疗。在这两种情况下，第三次治疗后,所有结局均有所改善,3个月时进一步改善.
结论：MLD可能提供非侵入性，解决咳嗽等长期COVID症状的非药物方法，呼吸困难,和疲劳。
